| pubmed-article:11235955 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11235955 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:11235955 | lifeskim:mentions | umls-concept:C0025932 | lld:lifeskim |
| pubmed-article:11235955 | lifeskim:mentions | umls-concept:C0025286 | lld:lifeskim |
| pubmed-article:11235955 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:11235955 | lifeskim:mentions | umls-concept:C0913469 | lld:lifeskim |
| pubmed-article:11235955 | lifeskim:mentions | umls-concept:C1947982 | lld:lifeskim |
| pubmed-article:11235955 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:11235955 | pubmed:dateCreated | 2001-3-8 | lld:pubmed |
| pubmed-article:11235955 | pubmed:abstractText | The authors have previously demonstrated that modulation of the growth hormone (GH)/insulin-like growth factor-I (IGF-I) axis can significantly affect meningioma growth in vitro. These studies were performed to evaluate the efficacy of GH receptor blockade in vivo. | lld:pubmed |
| pubmed-article:11235955 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11235955 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11235955 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:11235955 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11235955 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11235955 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11235955 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11235955 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11235955 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11235955 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:11235955 | pubmed:issn | 0022-3085 | lld:pubmed |
| pubmed-article:11235955 | pubmed:author | pubmed-author:HillHH | lld:pubmed |
| pubmed-article:11235955 | pubmed:author | pubmed-author:BennettW FWF | lld:pubmed |
| pubmed-article:11235955 | pubmed:author | pubmed-author:OOIS KSK | lld:pubmed |
| pubmed-article:11235955 | pubmed:author | pubmed-author:ScarlettJ AJA | lld:pubmed |
| pubmed-article:11235955 | pubmed:author | pubmed-author:FriendK EKE | lld:pubmed |
| pubmed-article:11235955 | pubmed:author | pubmed-author:FlyvbjergAA | lld:pubmed |
| pubmed-article:11235955 | pubmed:author | pubmed-author:McCutcheonI... | lld:pubmed |
| pubmed-article:11235955 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11235955 | pubmed:volume | 94 | lld:pubmed |
| pubmed-article:11235955 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11235955 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11235955 | pubmed:pagination | 487-92 | lld:pubmed |
| pubmed-article:11235955 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:11235955 | pubmed:meshHeading | pubmed-meshheading:11235955... | lld:pubmed |
| pubmed-article:11235955 | pubmed:meshHeading | pubmed-meshheading:11235955... | lld:pubmed |
| pubmed-article:11235955 | pubmed:meshHeading | pubmed-meshheading:11235955... | lld:pubmed |
| pubmed-article:11235955 | pubmed:meshHeading | pubmed-meshheading:11235955... | lld:pubmed |
| pubmed-article:11235955 | pubmed:meshHeading | pubmed-meshheading:11235955... | lld:pubmed |
| pubmed-article:11235955 | pubmed:meshHeading | pubmed-meshheading:11235955... | lld:pubmed |
| pubmed-article:11235955 | pubmed:meshHeading | pubmed-meshheading:11235955... | lld:pubmed |
| pubmed-article:11235955 | pubmed:meshHeading | pubmed-meshheading:11235955... | lld:pubmed |
| pubmed-article:11235955 | pubmed:meshHeading | pubmed-meshheading:11235955... | lld:pubmed |
| pubmed-article:11235955 | pubmed:meshHeading | pubmed-meshheading:11235955... | lld:pubmed |
| pubmed-article:11235955 | pubmed:meshHeading | pubmed-meshheading:11235955... | lld:pubmed |
| pubmed-article:11235955 | pubmed:meshHeading | pubmed-meshheading:11235955... | lld:pubmed |
| pubmed-article:11235955 | pubmed:meshHeading | pubmed-meshheading:11235955... | lld:pubmed |
| pubmed-article:11235955 | pubmed:meshHeading | pubmed-meshheading:11235955... | lld:pubmed |
| pubmed-article:11235955 | pubmed:meshHeading | pubmed-meshheading:11235955... | lld:pubmed |
| pubmed-article:11235955 | pubmed:meshHeading | pubmed-meshheading:11235955... | lld:pubmed |
| pubmed-article:11235955 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11235955 | pubmed:articleTitle | Antitumor activity of the growth hormone receptor antagonist pegvisomant against human meningiomas in nude mice. | lld:pubmed |
| pubmed-article:11235955 | pubmed:affiliation | Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, Houston, USA. imccutch@notes.mdacc.tmc.edu | lld:pubmed |
| pubmed-article:11235955 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11235955 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11235955 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11235955 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11235955 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11235955 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11235955 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11235955 | lld:pubmed |
